Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-12-13
1995-08-22
Higel, Floyd D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546118, A61K 31535, A61K 31435, C07D47104
Patent
active
054440688
ABSTRACT:
Imidazo-fused iso- and heterocycles, process for their preparation, compositions containing them and their use
A compound of the formula ##STR1## in which the symbols have the following meaning: X is a monocyclic radical having 3,4 or 5 ring atoms,
REFERENCES:
patent: 4594421 (1986-06-01), Bellani et al.
patent: 4612323 (1986-09-01), Kisida et al.
patent: 4663339 (1987-05-01), Kisida et al.
patent: 4880804 (1989-11-01), Carini et al.
patent: 4987145 (1991-01-01), Kisida et al.
patent: 5021443 (1991-06-01), Bru-Magniez et al.
patent: 5087702 (1992-02-01), Chen et al.
patent: 5102880 (1992-04-01), Chakravarty et al.
patent: 5128356 (1992-06-01), Naka et al.
patent: 5158327 (1992-07-01), Chakravarty et al.
patent: 5177074 (1993-01-01), Allen et al.
patent: 5223499 (1993-06-01), Greenlee et al.
Derwent Abstract DE 40 25 358 A1 (1993).
Derwent Abstract Japanese Patent No. 4 235973 (1993).
Derwent Abstract EP 0 420 237 (1993).
Gerhards Hermann
Heitsch Holger
Kleemann Heinz-Werner
Scholkens Bernward
Wagner Adalbert
Higel Floyd D.
Hoechst Aktiengesellschaft
LandOfFree
Imidazopyridine derivatives as angiotensin II receptor antagonis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazopyridine derivatives as angiotensin II receptor antagonis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazopyridine derivatives as angiotensin II receptor antagonis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2142029